Project description
Biochemical characterisation of in vitro brain organoids
Neuropsychiatric and neurological disorders are characterised by complex symptoms and are difficult to classify and study due to a lack of reliable biological models. The EU-funded BRAINtSERS project aims to test the accuracy of protocols involving current brain organoids to represent an in vitro model of the brain and to further promote their technological development thorough the use of human stem cells. Researchers plan to characterise these brain organoids during all developmental stages and identify key biomolecules. Long-term, the BRAINtSERS in vitro system will have the potential to be applied in basic research but also for pharmaceutical testing, addressing a medical issue of great social and economic importance.
Objective
Neuropsychiatric disorders and neurological diseases have a devastating impact on patients’ lives and represent a heavy social and economic load for global societies. Despite the great social and economic importance, the complex symptomatology together with the lack of objective analysis methodology and the limitation of current biological models have made disorders difficult to classify and study. The recent development of brain organoids derived from human stem cells have enormous potential as a physiologically accurate downscaled in vitro model of the human brain. Even though this system offers promising approach for investigating the phenotypic foundation of these complex disorders, the lack of a reliable and non-disruptive system for investigating their properties limits their applicability in both basic research and pharmaceutical testing. The BRAINtSERS project aims to respond to this need combining advanced brain organoid models together with surface-enhanced Raman spectroscopy (SERS), providing a multidimensional dataset of a developing human neuronal tissue resolved both in time and space.
In detail, the action will provide: (i) a label-free, highly sensitive technique for quantification and detection of biomolecules in brain organoids, (ii) a minimally-invasive system for cellular phenotyping, thus a non-destructive method for characterization of brain organoids during all developmental stages. Complementarily, the ER will deliver (iii) SERS-active bio-mimetic devices conceived for integration with organoid model and its genesis.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
- natural sciencesbiological sciencesbiochemistrybiomolecules
- medical and health sciencesmedical biotechnologycells technologiesstem cells
- natural sciencesphysical sciencesopticsspectroscopy
You need to log in or register to use this function
Keywords
Programme(s)
Funding Scheme
MSCA-IF - Marie Skłodowska-Curie Individual Fellowships (IF)Coordinator
16163 Genova
Italy